NO DIFFERENCE IN OVERALL SURVIVAL BETWEEN R-CHOP AND R-EPOCH AMONG… by Tylan Magnusson

Retrospective Flatiron EMR data presented at EHA2021 showed no difference in OS in 154 DH/THL patients treated with RCHOP vs EPOCH. 4 years OS was 54.5% vs vs. 49.6%, respectively. Single hit MYC-R patients had even worse outcomes.

Read the full article here

Related Articles